01 1PolyPeptide Group
01 1VASOPRESSIN
01 1Switzerland
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-03-02
Pay. Date : 2017-10-04
DMF Number : 32116
Submission : 2017-10-03
Status : Active
Type : II
20
Polypeptide Laboratories Sweden Ab, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is VASOPRESSIN, with a corresponding US DMF Number 32116.
Remarkably, this DMF maintains an Active status since its submission on October 03, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 02, 2018, and payment made on October 04, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
